Cargando…
Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
Autor principal: | White-Al Habeeb, Nicole M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474429/ https://www.ncbi.nlm.nih.gov/pubmed/28109828 http://dx.doi.org/10.1016/j.ebiom.2017.01.012 |
Ejemplares similares
-
Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma
por: Zheng, Junfang, et al.
Publicado: (2016) -
Molecular Analysis of the Prostacyclin Receptor’s Interaction with the PDZ1 Domain of Its Adaptor Protein PDZK1
por: Birrane, Gabriel, et al.
Publicado: (2013) -
Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis
por: Turner, Elizebeth C., et al.
Publicado: (2011) -
IL-1β-Induced Downregulation of the Multifunctional PDZ Adaptor PDZK1 Is Attenuated by ERK Inhibition, RXRα, or PPARα Stimulation in Enterocytes
por: Luo, Min, et al.
Publicado: (2017) -
Downregulation of the NHE3-Binding PDZ-Adaptor Protein PDZK1 Expression during Cytokine-Induced Inflammation in Interleukin-10–Deficient Mice
por: Lenzen, Henrike, et al.
Publicado: (2012)